Literature DB >> 850692

Taste aversion disruption by drug pretreatment: dissociative and drug-specific effects.

D S Cannon, T B Baker, R F Berman.   

Abstract

Disruption of taste aversion learning following the administration of the same drug prior to and during conditioning (intra-agent disruption) was shown to be greater than disruption following the administration of one drug prior to conditioning and another during conditioning (inter-agent disruption). Comparable dosages of ethanol and lithium chloride served as unconditioned stimuli. Inter-agent disruptions are attributed to a dissociation of conditioned and unconditioned stimuli, while intra-agent disruptions are attributed to both a dissociative effect and drug-specific effects. Intra-agent disruption was correlated with an independent measure of tolerance, suggesting tolerance constitutes at least a portion of the drug-specific effects.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 850692     DOI: 10.1016/0091-3057(77)90164-2

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  3 in total

1.  Sex differences in the effects of ethanol pre-exposure during adolescence on ethanol-induced conditioned taste aversion in adult rats.

Authors:  Luke K Sherrill; Claire Berthold; Wendy A Koss; Janice M Juraska; Joshua M Gulley
Journal:  Behav Brain Res       Date:  2011-07-08       Impact factor: 3.332

2.  Rats preexposed to MDMA display attenuated responses to its aversive effects in the absence of persistent monoamine depletions.

Authors:  Daniel L Albaugh; Jennifer A Rinker; Michael H Baumann; Jacquelyn R Sink; Anthony L Riley
Journal:  Psychopharmacology (Berl)       Date:  2011-03-05       Impact factor: 4.530

3.  Chronic alcohol consumption in alcohol-preferring P rats attenuates subsequent conditioned taste aversion produced by ethanol injections.

Authors:  R B Stewart; W J McBride; L Lumeng; T K Li; J M Murphy
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.